[go: up one dir, main page]

ZA200903609B - Motilide polymorphs - Google Patents

Motilide polymorphs

Info

Publication number
ZA200903609B
ZA200903609B ZA200903609A ZA200903609A ZA200903609B ZA 200903609 B ZA200903609 B ZA 200903609B ZA 200903609 A ZA200903609 A ZA 200903609A ZA 200903609 A ZA200903609 A ZA 200903609A ZA 200903609 B ZA200903609 B ZA 200903609B
Authority
ZA
South Africa
Prior art keywords
motilide
polymorphs
motilide polymorphs
Prior art date
Application number
ZA200903609A
Other languages
English (en)
Inventor
Peter Licari
Jorge Galazzo
Greg Buchanan
Alexander Redvers Eberlin
Mark Eddleston
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of ZA200903609B publication Critical patent/ZA200903609B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Steroid Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
ZA200903609A 2006-12-05 2009-05-25 Motilide polymorphs ZA200903609B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US87310106P 2006-12-05 2006-12-05

Publications (1)

Publication Number Publication Date
ZA200903609B true ZA200903609B (en) 2010-07-28

Family

ID=39492676

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200903609A ZA200903609B (en) 2006-12-05 2009-05-25 Motilide polymorphs

Country Status (17)

Country Link
US (2) US7872109B2 (fr)
EP (1) EP2104680B1 (fr)
JP (2) JP2008143898A (fr)
KR (1) KR101120483B1 (fr)
CN (1) CN101547931B (fr)
AR (1) AR064107A1 (fr)
AU (1) AU2007330456B2 (fr)
BR (1) BRPI0719565A2 (fr)
CA (1) CA2670482C (fr)
ES (1) ES2401467T3 (fr)
IL (1) IL198449A0 (fr)
MX (1) MX2009005977A (fr)
NZ (1) NZ576719A (fr)
RU (1) RU2422453C2 (fr)
TW (1) TWI345566B (fr)
WO (1) WO2008068593A2 (fr)
ZA (1) ZA200903609B (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10165774B2 (en) 2013-03-05 2019-01-01 Ecolab Usa Inc. Defoamer useful in a peracid composition with anionic surfactants
TWI710372B (zh) * 2014-05-16 2020-11-21 日商拉夸里亞創藥股份有限公司 用於胃輕癱之5-ht4受體激動劑
US12096768B2 (en) 2019-08-07 2024-09-24 Ecolab Usa Inc. Polymeric and solid-supported chelators for stabilization of peracid-containing compositions

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
YU35369B (en) 1973-01-19 1980-12-31 Pliva Zagreb Process for preparing n-(benzenesulfonyl)-erythromycilamine derivatives
US3983103A (en) 1973-01-19 1976-09-28 Pliva Pharmaceutical And Chemical Works N-(Benzenesulfonyl)-erythromycylamine derivatives
US3855200A (en) 1973-04-23 1974-12-17 Polska Akademia Nauk Instytut Process for preparing 8-hydroxyerthromycin a and intermediates therefor
YU35363B (en) 1974-01-14 1980-12-31 Pliva Zagreb Process for obtaining n-(benzene-sulfonyl)-5-0desosaminyl-erythromycilamine derivatives
IT1196041B (it) 1984-03-08 1988-11-10 Pierrel Spa Emichetali di (8s)-8-fluoroeritromicine,il procedimento per la loro preparazione e le formulazioni adatte alla somministrazione orale che contengono i prodotti
JPS60218321A (ja) 1984-04-13 1985-11-01 Satoshi Omura 消化管収縮運動促進剤
US5175150A (en) 1985-08-31 1992-12-29 Kitasato, Kenkyusho Erythromycin derivative
US5008249A (en) 1985-08-31 1991-04-16 Kitasato Kenkyusho Therapeutic method of stimulating digestive tract contractile motion in mammals
IL114589A (en) 1990-11-21 1999-12-22 Roussel Uclaf Intermediates for the preparation of erythromycin derivatives
JPH06509326A (ja) 1991-04-09 1994-10-20 アボツト・ラボラトリーズ 大環式ラクタムプロキネティック剤
US5523418A (en) 1991-04-09 1996-06-04 Abbott Laboratories Macrocyclic lactam prokinetic agents
ZA922777B (en) * 1991-04-29 1993-10-15 Lilly Co Eli Pharmaceutical formulation containing dirithromycin
DE4200145A1 (de) * 1992-01-07 1993-07-08 Kali Chemie Pharma Gmbh 7,10-epoxy-oxacyclododecan-derivate, verfahren und zwischenprodukte zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
IL104437A (en) 1992-01-21 1997-03-18 Abbott Lab 4)-deoxyerythromycin derivatives
ATE138925T1 (de) 1992-03-19 1996-06-15 Takeda Chemical Industries Ltd Erythromycinderivate, herstellung und verwendung davon
MY113693A (en) 1992-05-26 2002-05-31 Chugai Pharmaceutical Co Ltd Erythromycin derivatives having an enterokinesis stimulating action
ZA966601B (en) 1995-08-03 1997-02-19 Chugai Pharmaceutical Co Ltd Process for producing erythromycin derivatives.
US5712253A (en) 1996-06-18 1998-01-27 Abbott Laboratories Macrocyclic 13-membered ring derivatives of erythromycins A and B
WO1998004574A1 (fr) * 1996-07-29 1998-02-05 Abbott Laboratories Preparation de la forme cristalline ii de la clarithromycine
DE19644195A1 (de) * 1996-10-24 1998-04-30 Solvay Pharm Gmbh 10,13,15-Trioxatricyclo[9.2.1.1.·9·.·6·]-pentadecanon-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
US5922849A (en) 1996-11-22 1999-07-13 Abbott Laboratories Process for preparation of N-demethyl-4"-deoxy-erthromycins A and B
AU9646098A (en) 1997-10-29 1999-05-17 Taisho Pharmaceutical Co., Ltd. Erythromycin a derivatives
US6084079A (en) 1998-05-15 2000-07-04 Keyes; Robert F. Process for preparing N-demethyl-N-alkyl erythromycin derivatives
US6562795B2 (en) 2000-02-18 2003-05-13 Kosan Biosciences, Inc. Motilide compounds
US20020094962A1 (en) 2000-12-01 2002-07-18 Gary Ashley Motilide compounds
WO2002064092A2 (fr) 2001-02-15 2002-08-22 Kosan Biosciences, Inc. Procédé pour évaluer l'efficacité thérapeutique
JP2002241391A (ja) 2001-02-15 2002-08-28 Taisho Pharmaceut Co Ltd エリスロマイシンａ誘導体
CN100363359C (zh) 2002-08-29 2008-01-23 菲塞股份有限公司 运动内酯化合物
US7407941B2 (en) 2003-08-26 2008-08-05 Pfizer, Inc. N-desmethyl-N-substituted-11-deoxyerythromycin compounds
US20050113319A1 (en) 2003-08-26 2005-05-26 Christopher Carreras 11-Deoxy-6,9-ether erythromycin compounds
US7211568B2 (en) 2003-12-18 2007-05-01 Kosan Biosciences Incorporated 9-Desoxoerythromycin compounds as prokinetic agents
ES2331739T3 (es) * 2004-05-06 2010-01-14 Glaxosmithkline Istrazivacki Centar Zagreb D.O.O. Macrolidos que contienen enlaces ester utiles para el tratamiento de infecciones microbianas.
US7582611B2 (en) * 2005-05-24 2009-09-01 Pfizer Inc. Motilide compounds
US20070135362A1 (en) 2005-12-08 2007-06-14 Yaoquan Liu Method for demethylating the 3'-dimethylamino group of erythromycin compounds

Also Published As

Publication number Publication date
JP2012107075A (ja) 2012-06-07
EP2104680A2 (fr) 2009-09-30
AR064107A1 (es) 2009-03-11
BRPI0719565A2 (pt) 2013-12-10
RU2422453C2 (ru) 2011-06-27
US7872109B2 (en) 2011-01-18
KR20090079979A (ko) 2009-07-22
CA2670482A1 (fr) 2008-06-12
AU2007330456B2 (en) 2011-03-03
US20080146654A1 (en) 2008-06-19
JP2008143898A (ja) 2008-06-26
US8030282B2 (en) 2011-10-04
TW200835691A (en) 2008-09-01
IL198449A0 (en) 2010-02-17
WO2008068593A3 (fr) 2008-11-06
MX2009005977A (es) 2009-06-17
CN101547931B (zh) 2012-11-14
AU2007330456A1 (en) 2008-06-12
CA2670482C (fr) 2011-10-11
ES2401467T3 (es) 2013-04-19
RU2009117153A (ru) 2011-01-20
EP2104680B1 (fr) 2013-01-09
CN101547931A (zh) 2009-09-30
WO2008068593A8 (fr) 2009-05-22
NZ576719A (en) 2012-01-12
KR101120483B1 (ko) 2012-02-29
US20100227829A1 (en) 2010-09-09
WO2008068593A2 (fr) 2008-06-12
TWI345566B (en) 2011-07-21

Similar Documents

Publication Publication Date Title
IL195029A0 (en) Polymorphs
GB0602424D0 (en) Compounds
GB0602046D0 (en) Compounds
EP1984379A4 (fr) Composes anti-arenaviridae
EP2082022A4 (fr) Composés
EP2195319A4 (fr) Polymorphes du valomaciclovir
EP2004174A4 (fr) Composés de naphtalènedione
ZA200903609B (en) Motilide polymorphs
GB0602042D0 (en) Compounds
AP2009004767A0 (en) Cubstituted azolin-2-yl-amino compounds
EP1973905A4 (fr) Composes
IL214253A0 (en) Tetomilast polymorphs
GB0602560D0 (en) Compounds
GB0600427D0 (en) Compounds
GB0602412D0 (en) Compounds
GB0602454D0 (en) Compounds
GB0602559D0 (en) Compounds
GB0601505D0 (en) Compounds
GB0600929D0 (en) Compounds
GB0602040D0 (en) Compounds
GB0600426D0 (en) Compounds
GB0602455D0 (en) Compounds
GB0602856D0 (en) Compounds
GB0602853D0 (en) Compounds
GB0602451D0 (en) Compounds